UiPath shares are higher as investors focus on two near-term catalysts: an active capital-return story and the next earnings checkpoint. The company has a board-authorized program to repurchase up to $500 million of Class A shares, which can provide incremental demand for the stock and signal confidence in valuation and cash generation. (ir.uipath.com)

UiPath disclosed that its board authorized a new $500 million share repurchase program (authorized March 5, 2026), following completion of a prior repurchase program. The authorization does not have a set expiration date, and purchases may be executed over time via open-market and other methods, which keeps buyback support in the narrative even when there is no single-day repurchase disclosure. (ir.uipath.com)

Alongside its fiscal Q4 and full-year FY2026 results, UiPath provided FY2027 guidance that sets the benchmark for how quickly its agentic automation strategy translates into growth and operating leverage. The company guided Q1 FY2027 revenue of $395 million to $400 million and ARR of $1.894 billion to $1.899 billion (as of April 30, 2026), and it guided full-year FY2027 revenue of $1.754 billion to $1.759 billion with ARR of $2.051 billion to $2.056 billion (as of January 31, 2027). (ir.uipath.com)

UiPath is scheduled to report fiscal Q1 2027 results after the market closes on Thursday, May 28, 2026, putting the stock back into an “earnings setup” window where positioning, short-term sentiment, and expectation resets can amplify moves. With PATH trading near $10–$11, today’s gain looks consistent with a pre-earnings re-rating attempt tied to buyback support and a renewed focus on whether ARR and margins are tracking toward FY2027 targets. (benzinga.com)